The cost of 15 prescription drugs will be lowered following negotiations with the Centers for Medicare and Medicaid Services. Some negotiated costs for the drugs on the list include: - Ozempic, Rybelsus and Wegovy, for Type 2 diabetes, cardiovascular disease and weight loss - $274 negotiated price, down from the $959 - Tradjenta, Type 2 diabetes - $78, down from $488 - Ibrance, breast cancer - $7,871, down from $15,741 - Breo Ellipta, asthma, chronic obstructive pulmonary disease - $67, down fro

13K views · 307 reactions | Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services discusses the future of Medicaid for Americans and how they can ensure the right to be on it. READ MORE: https://bit.ly/4jQv2WZ | The National Desk - TND | Facebook

Dr. Mehmet Oz, the administrator of the Centers for Medicare & Medicaid Services, joined Face The Nation on Sunday to discuss changes after the passage of President Trump's "big, beautiful bill." Read more of Oz’s interview with Margaret Brennan: https://www.cbsnews.com/news/dr-mehmet-oz-cms-administrator-face-the-nation-08-03-2025/ | Face The Nation